To our knowledge, this is the first study to analyze the prevalence of AIP gene mutations and mutations in genes that have been associated with neuroendocrine tumors in series of tumors from patients presenting with both pituitary adenomas and DTCs. Here, AIP is linked to neuroendocrine neoplasm.